DEPSYL™ Offers an Alternative Solution to Blood Sugar Management
CINCINNATI, Feb. 18, 2011 /PRNewswire/ -- Global health expenditures to prevent and treat diabetes and its complications will total at least $376 billion in 2010. By 2030, this number will exceed some $490 billion. Expenditures spent on diabetes care are not evenly distributed across age and gender groups. More than three-quarters of the global expenditure in 2010 will be used for persons who are between 50 and 80 years of age. Also, more money is expected to be spent on diabetes care for women than for men. The United States of America will spend $198 billion, or 52.7% of global expenditure on diabetes related initiatives.
At the societal level, diabetes leads to loss in productivity and economic growth. The American Diabetes Association estimated that the US economy lost $58 billion, equivalent to about half of the direct health care expenditure on diabetes in 2007, as a result of lost earnings due to lost work days, restricted activity days, lower productivity at work, mortality and permanent disability caused by diabetes. Source: IDF Diabetes Atlas fourth edition
DEPSYL™ offers an alternative solution to blood sugar management and is comprised of a naturally derived blend of herbs, vitamins and fatty acids that help support healthy blood sugar levels without changing eating behavior. The formula is created in a manner which maximizes the potency and absorption of natural ingredients by using a unique 6-step proprietary blending and extraction process.
DEPSYL™ Key Ingredients
BANABA |
|
CINNAMON CASSIA |
|
GYMNEMA SYLVESTRE |
|
FENUGREEK SEED |
|
SALACIA OBLONGA |
|
ALPHA LIPOIC ACID |
|
CHROMIUM |
|
Each DEPSYL™ component has been backed up by independent and academic research. Complete ingredient claims can be provided. The claims are based upon the substantiation process. This process was based upon a Literature Review generated and prepared by Natural Standard. The Ingredient Claims were prepared by Venable LLP based upon their review and scrutiny of the Literature Review.
According to DEPSYL™ Executive Vice President, Myron Wolff, "Diabetes is a real threat to our healthcare system and to individuals. Currently, diabetes is the third leading cause of death in the United States and is the foremost reason for adult blindness, kidney failure and limb amputation, and a large contributor to heart attacks and strokes." He went on to explain that information about negative effects of diabetes is available; nevertheless many people think diabetes will not strike them or their loved ones. To control diabetes, people need to make life adjustments. Wolff emphasized, "Ignored diabetes can lead to blindness, kidney failure, heart disease, nerve damage, limb amputations and even death."
* "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
For more information contact: |
||
Rod Hammons |
Jo Ann Reilly |
|
DEPSYL™ www.DEPSYL.com |
Pegasus Marketing and Public Relations |
|
Cell: 513.910.0856 |
Cell: 513-739-7774 |
|
SOURCE DEPSYL
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article